| Aveo fills enrollment of renal cell carcinoma trial - Mass High Tech |
|
|
Mass High TechAveo Pharmaceuticals Inc. has filled its enrollment target of 500 patients for a Phase 3 clinical trial for its renal cell carcinoma ...AVEO Achieves Enrollment Target Ahead of Schedule for Pivotal Phase 3 Trial of ... read more |